News and Events

Latest news about MetaBiomics™ milestones, events, research, products and services.

Click here to view the News and Events Page

Mission

For the past 10 years, Metabiomics™ LLC has been a leader in human microbiome research, specializing in functional microbiomics and systems biology, and pioneering advances in microbial DNA sequencing methods, clinical research, and in-vitro diagnostics.

Metabiomics™ has developed a new microbiomic diagnostics technology for early detection and monitoring of polymicrobial and immunological diseases such as inflammatory bowel disease, colon disease/cancer, HIV infection, and alcoholic liver disease. This new non-invasive diagnostic technology is less expensive, more sensitive, and more accurate than currently available diagnostic procedures.

Click here to view the Mission Page

Management

Our management team builds on a track record of many years of provenexperience and successful innovation in entrepreneurial business development, science, and engineering. Dr. Thomas J. Kuehn and Dr. Patrick Gillevet co-founded MetaBiomics™ LLC in 2000. Dr. Kuehn contributes his 25 years experience in the development, manufacturing, marketing, sales, and service of advanced analytical instrumentation, biotechnology, and information technology. He was the former cofounder, inventor, and President of Viking Instruments Corporation pioneering the field of portable analytical instrumentation. Dr. Gillevet adds another 25 years experience in research and development in the field of molecular ecology, genomics, and microbiomics. He was formerly the Director of the Harvard Genome Laboratory at Harvard University and is presently the Director of the MicroBiome Analysis Center (MBAC) at George Mason University.

Click here to view the Management Page

Partners

MetaBiomics™ LLC has joined with George Mason University, Rush University Medical Center and, other leading institutions to advance research and development on the Human Microbiome.   The initial focus of our collaborative research has been investigation of clinical dysbiosis of the Human Microbiome that residing in the gut, mouth, urogenital, and respiratory tract.  Collaborations with the MicroBiome Analysis Center (MBAC) at GMU have been focusing on basic research in microbial ecology, polymicrobial diseases, and other molecular ecology applications. Our collaborations with Rush Medical Center has been developing technology and studying the gut microbiota in IBD and has begun to characterize the microbiota in HIV.

Click here to view the Partners Page

Contact us for more info